HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prepro-thyrotropin-releasing hormone 178-199 exerts partial protection against cerebral ischemia in adult rats.

Abstract
We examined in the present study the effects of the centrally administered prepro-thyrotropin-releasing-hormone 178-199 (prepro-TRH 178-199) on cerebral ischemia induced by ligation of the middle cerebral artery (MCA) in adult Sprague-Dawley rats. Animals were intracerebrally injected with prepro-TRH 178-199 (6 microg/kg or 200 microg/kg) or saline 1-2 h before ligation of MCA. Ischemic animals that received prepro-TRH 178-199, regardless of dosage, displayed some amelioration (20%) of motor asymmetry associated with MCA ligation, while ischemic animals that received saline continued to exhibit significant asymmetrical behaviors. Interestingly, triphenyltetrazolium chloride staining (a marker for tissue metabolic activity) revealed that four of five ischemic animals that received 200 microg/kg prepro-TRH 178-199 showed a marked reduction (90-100%) in the infarction of the frontal cortex, although the posterior sections of the cortex remained infarcted. In contrast, ischemic animals that received 6 microg/kg prepro-TRH 178-199 demonstrated infarction that did not differ in size and extent from those that received saline. Post hoc examination revealed that ischemic animals treated with 200 microg/kg prepro-TRH 178-199 had significantly lower corticosterone (CORT) levels (115+/-23 ng/ml) than ischemic animals treated with 6 microg/kg prepro-TRH 178-199 or saline (288+/-51 ng/ml). The present observation provides the first evidence that prepro-TRH 178-199 can promote neuroprotection against cerebral ischemia.
AuthorsC V Borlongan, C E Stahl, E Redei, Y Wang
JournalNeuroreport (Neuroreport) Vol. 10 Issue 17 Pg. 3501-5 (Nov 26 1999) ISSN: 0959-4965 [Print] England
PMID10619633 (Publication Type: Journal Article)
Chemical References
  • Neuroprotective Agents
  • Peptide Fragments
  • Protein Precursors
  • prepro-thyrotropin-releasing hormone (178-199)
  • Thyrotropin-Releasing Hormone
  • Hydrocortisone
Topics
  • Aging
  • Animals
  • Brain Ischemia (blood, drug therapy, physiopathology)
  • Cerebral Infarction (blood, physiopathology, prevention & control)
  • Frontal Lobe (drug effects, pathology, physiopathology)
  • Hydrocortisone (blood)
  • Male
  • Motor Activity (drug effects)
  • Neuroprotective Agents (administration & dosage, pharmacology)
  • Peptide Fragments (administration & dosage, pharmacology)
  • Protein Precursors (administration & dosage, pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Thyrotropin-Releasing Hormone (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: